Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
What the trial team says
This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors
Key facts
- Registry number
- NCT05636618
- Stage of testing
- Phase 1/Phase 2
- Conditions studied
- Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic, Gastroenteropancreatic Neuroendocrine Tumor, Bronchial Neuroendocrine Tumor, Paraganglioma, Pheochromocytoma, Meningioma
Where it is running
This trial lists 20 sites.
-
Florida
- Mayo Clinic (Jacksonville)
- Biogenix Molecular (Miami)
- Advent Health Radiation Oncology at Central Florida (Orlando)
-
Illinois
- The University of Chicago (Chicago)
-
Iowa
- University of Iowa (Iowa City)
-
Kentucky
- University of Kentucky (Lexington)
-
Maryland
- Johns Hopkins (Baltimore)
-
Michigan
- Barbara Ann Karmanos Cancer Institute (Detroit)
- BAMF Health (Grand Rapids)
- Michigan Health Professionals (Troy)
-
Minnesota
- Mayo Clinic (Rochester)
-
Missouri
- Washington University (St Louis)
-
Nebraska
- Nebraska Cancer Specialists (Omaha)
-
North Carolina
- University of North Carolina (Chapel Hill)
-
Ohio
- UH Cleveland Medical Center (Cleveland)
- Ohio State University (Columbus)
-
Tennessee
- Vanderbilt-Ingram Cancer Center (Nashville)
-
Virginia
- Virginia Cancer Specialists (Fairfax)
-
Washington
- Fred Hutchinson Cancer Center (Seattle)
-
Wisconsin
- Froedtert Medical College of Wisconsin (Milwaukee)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.